National Lipid Association Releases Official Scientific Statement on Coronary Artery Calcium Scoring for ASCVD Risk Reduction
JACKSONVILLE, Fla., Dec. 12, 2020 (GLOBE NEWSWIRE) The National Lipid Association (NLA) today announced the release of its official scientific statement on coronary artery calcium (CAC) scoring for atherosclerotic cardiovascular disease (ASCVD) risk reduction. The statement provides updates on the evidence-based appropriate use of CAC scoring and makes practical recommendations to aid clinicians in primary prevention treatment decision-making in contemporary clinical practice.
“Coronary calcium scoring is the best available non-invasive marker of cardiovascular risk,” Stated the corresponding author, Carl E. Orringer, MD, Associate Professor Medicine at the University of Miami, Miller School of Medicine, Cardiovascular Division. “This manuscript addresses the key questions that clinicians have about this test and provides up-to-date, evidence-based r
Share:
JACKSONVILLE, Fla., Dec. 12, 2020 (GLOBE NEWSWIRE) The National Lipid Association (NLA) today announced the release of its official scientific statement on coronary artery calcium (CAC) scoring for atherosclerotic cardiovascular disease (ASCVD) risk reduction. The statement provides updates on the evidence-based appropriate use of CAC scoring and makes practical recommendations to aid clinicians in primary prevention treatment decision-making in contemporary clinical practice. Coronary calcium scoring is the best available non-invasive marker of cardiovascular risk, Stated the corresponding author, Carl E. Orringer, MD, Associate Professor Medicine at the University of Miami, Miller School of Medicine, Cardiovascular Division. This manuscript addresses the key questions that clinicians have about this test and provides up-to-date, evidence-based recommendations for optimal use of this technology for cardiovascular disease prevention.